Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Flavoxate hydrochloride

Flavoxate hydrochloride

pharmaceutical raw materials
Flavoxate hydrochloride structure

Flavoxate hydrochloride 

structure
  • CAS No:

    3717-88-2

  • Formula:

    C24H25NO4.ClH

  • Chemical Name:

    Flavoxate hydrochloride

  • Synonyms:

    4H-1-Benzopyran-8-carboxylic acid,3-methyl-4-oxo-2-phenyl-,2-(1-piperidinyl)ethyl ester,hydrochloride (1:1);4H-1-Benzopyran-8-carboxylic acid,3-methyl-4-oxo-2-phenyl-,2-piperidinoethyl ester,hydrochloride;4H-1-Benzopyran-8-carboxylic acid,3-methyl-4-oxo-2-phenyl-,2-(1-piperidinyl)ethyl ester,hydrochloride;1-Piperidineethanol,3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate (ester),hydrochloride;Flavoxate hydrochloride;Piperidinoethyl-3-methylflavone-8-carboxylate hydrochloride;DW 61;Peflate;Rec 7/0040;Spasmal;Urispas;Bladderon;Genurin;Patricin;Spasuret;NSC 114649;2-(Piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate hydrochloride

  • Categories:

    Active Pharmaceutical Ingredients  >  Urinary System Drugs

Description

Flavoxate Hydrochloride(DW-61 Hydrochloride) is a muscarinic AChR antagonist used in various urinary syndromes and as an antispasmodic.Target: mAChRFlavoxate displaces [3H]nitrendipine on the Ca2+ channels binding sites with IC50 of 254 μM [1]. Flavoxate (>10 μM) suppresses carbachol-induced contractions in isolated rat detrusor strips with pD value of 4.55. Flavoxate (>10 μM) suppresses Ca2+-induced contractions in isolated rat detrusor strips with pIC50 value of 4.92 [2]. Flavoxate (0.


Flavoxate hydrochloride is the hydrochloride salt of flavoxate. It has a role as a muscarinic antagonist, an antispasmodic drug and a parasympatholytic. It contains a flavoxate(1+).|Flavoxate Hydrochloride is the hydrochloride salt form of flavoxate, a parasympatholytic agent with antispasmodic activity. Flavoxate hydrochloride competitively binds to muscarinic receptors, thereby preventing the actions of acetylcholine. This relaxes vascular smooth muscle, mainly of the urinary tract, and prevents smooth muscle contractions.|A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist.

Flavoxate hydrochloride Basic Attributes

427.92

427.155029

223-066-4

9C05J6089W

114649

DTXSID1047784

C47533

2934999090

Characteristics

55.8

5.15100

white solid

1.203g/cm3

232-234 °C

564.1ºC at 760 mmHg

294.9ºC

H2O: ~6.6 mg/mL

Refrigerator

LD50 i.v. in rats: 27.4 mg/kg (Cazzulani)

Safety Information

NONH for all modes of transport

3

22-36/37/38

26

DJ2450000

Xn

P301 + P312 + P330-P305 + P351 + P338

H302-H315-H319-H335

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 95 companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)|Drugs used in the treatment of urogenital conditions and diseases such as URINARY INCONTINENCE; PROSTATIC HYPERPLASIA; and ERECTILE DYSFUNCTION. (See all compounds classified as Urological Agents.)

Bladuril

Flavoxate hydrochloride Use and Manufacturing

Uses

Smooth muscle relaxant. Used as antispasmodic; in treatment of urinary incontinence This product is suitable for symptoms such as frequent urination, urgency, dysuria, dysuria and urinary incontinence caused by the following diseases: 1. Infectious diseases of the lower urinary tract (prostatitis, cystitis, urethritis, etc.). 2. Lower urinary tract obstructive diseases (early and mid-stage prostate hyperplasia, spasticity, functional urethral stricture). 3. After lower urinary tract instrument examination or surgery (prostate enucleation, urethral dilation, intravesical surgery). 4. Urethral syndrome. 5. Urgent urinary incontinence Urinary system medication

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:427.9
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:6
Exact Mass:427.1550360
Monoisotopic Mass:427.1550360
Topological Polar Surface Area:55.8
Heavy Atom Count:30
Complexity:631
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

This product is a smooth muscle relaxant. It has the function of inhibiting adenylate cyclase and phosphodiesterase, antagonizing calcium ions, and has a weak anti-muscarinic effect. It has a selective spasmolytic effect on the smooth muscles of the urogenital system, and can directly relieve the spasm of the smooth muscles of the urogenital system, relax the muscles, and eliminate frequent urination, urgency, urinary incontinence, and lower abdominal pain caused by urethral bladder smooth muscle spasm.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.

    France France
    Active
  • ISOCHEM

    France France
    Active
  • Chongqing Unger Dragon Pharmaceutical Co., Ltd.

    China China
    Active

Recommended Suppliers of Flavoxate hydrochloride

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.